Secondary prevention in early coronary disease

被引：2

作者：

Batalla, A ^{[1
]}

Cubero, GI

Réguero, JR

Hevia, S

机构：

[1] Cabuenes Hosp, Dept Cardiol, Gijon, Spain

[2] Univ Oviedo, Hosp Cent Asturias, Dept Cardiol, E-33080 Oviedo, Spain

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2000年 / 72卷 / 03期

关键词：

D O I：

10.1016/S0167-5273(99)00192-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：291 / 292

页数：2

共 6 条

[1]

[Anonymous], 1997, Eur Heart J, V18, P1569

[2] A British cardiac society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events) - Principal results [J].

Bowker, TJ ;

Clayton, TC ;

Ingham, J ;

McLennan, NR ;

Hobson, HL ;

Pyke, SDM ;

Schofield, B ;

Wood, DA .

HEART, 1996, 75 (04) :334-342

[3] Secondary prevention of myocardial infarction in Spain. PREVESE study [J].

deVelasco, JA ;

Cosin, J ;

Sendon, JLL ;

deTeresa, E ;

deOya, M ;

Carrasco, JL ;

Navarro, A .

REVISTA ESPANOLA DE CARDIOLOGIA, 1997, 50 (06) :406-415

[4]

PEDERSEN TR, 1994, LANCET, V344, P1383

[5] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[6]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

← 1 →